{"id":674,"date":"2025-03-17T18:18:39","date_gmt":"2025-03-17T18:18:39","guid":{"rendered":"https:\/\/cancerequality.eu\/?page_id=674"},"modified":"2025-05-26T08:07:15","modified_gmt":"2025-05-26T08:07:15","slug":"speakers-2025","status":"publish","type":"page","link":"https:\/\/cancerequality.eu\/lv\/speakers-2025\/","title":{"rendered":"Run\u0101t\u0101ji"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"speakers.php","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-674","page","type-page","status-publish","hentry"],"acf":{"speakers":[{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2021\/12\/409053_8164_2362x3543.jpg","name":"Olga Valci\u0146a","position":"Latvijas Onkolo\u0123ijas pacientu organiz\u0101ciju apvien\u012bbas \u201cOnkoalianse\u201d dibin\u0101t\u0101ja","description":"Olga Valci\u0146a ir melanomas pacientu atbalsta biedr\u012bbas \u201cSoli priek\u0161\u0101 melanomai\u201d dibin\u0101t\u0101ja un vad\u012bt\u0101ja. Melanomas paciente kop\u0161 2017. gada. Mg. biol. Olga Valci\u0146a ir viena no ener\u0123isk\u0101kaj\u0101m pacientu aizst\u0101v\u0113m Latvij\u0101, Latvijas onkolo\u0123ijas pacientu organiz\u0101ciju apvien\u012bbas \u201cOnkoalianse\u201d dibin\u0101\u0161anas iniciatore un t\u0101s valdes locekle. Vi\u0146as vad\u012bt\u0101 biedr\u012bba \u201cSoli priek\u0161\u0101 melanomai\u201d akt\u012bvi c\u012bn\u0101s par lab\u0101ku \u0101rst\u0113\u0161anas pieejam\u012bbu un kvalit\u0101ti melanomas pacientiem, kop\u0101 ar \u201cOnkoaliansi\u201d l\u012bdzdarbojoties Latvijas onkolo\u0123ijas politikas pilnveido\u0161an\u0101. Kop\u0161 2019. gada Olga Valci\u0146a ir iesaist\u012bjusies Eiropas Melanomas pacientu t\u012bkla aktivit\u0101t\u0113s, sekm\u0113jot to, ka Latvij\u0101 p\u0113d\u0113jos gados ir iev\u0113rojami uzlabojusies jaun\u0101ko z\u0101\u013cu pieejam\u012bba melanomas \u0101rst\u0113\u0161anai, tiek iev\u0113rotas starptautisk\u0101s vadl\u012bnijas melanomas diagnostik\u0101, terapij\u0101 un nov\u0113ro\u0161an\u0101. Olgas Valci\u0146as galvenais moto pacientu aizst\u0101v\u012bbas jom\u0101: \u201cIzgl\u012btoti pacienti dz\u012bvo ilg\u0101k un lab\u0101k. Ja pacienti v\u0113las re\u0101lus uzlabojumus, vi\u0146iem j\u0101b\u016bt gudriem, vienm\u0113r \u013coti labi sagatavotiem un j\u0101veido sava reput\u0101cija un atpaz\u012bstam\u012bba\u201d. P\u0113c izgl\u012bt\u012bbas Olga Valci\u0146a ir mikrobiolo\u0123e, p\u0101rtikas dro\u0161\u012bbas, dz\u012bvnieku vesel\u012bbas un vides zin\u0101tniskaj\u0101 instit\u016bt\u0101 BIOR ir direktora vietniece laboratoriju jaut\u0101jumos."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/03\/Adam-Sohn.jpg","name":"Adam Sohn","position":"Pacientu iesaistes risin\u0101jumu vad\u012bt\u0101js, IQVIA, ASV","description":"\u0100dams Sons ir pacientu iesaistes risin\u0101jumu vad\u012bt\u0101js, IQVIA, ASV, kur vi\u0146\u0161 vada komandu, kas fokus\u0113jas uz pacientu iesaistes veicin\u0101\u0161anu, jaunu komerci\u0101lo mode\u013cu izstr\u0101di un integr\u0113tu digit\u0101l\u0101s vesel\u012bbas risin\u0101jumu ievie\u0161anu. \u0100. Sona pieredze vesel\u012bbas apr\u016bpes nozar\u0113 ir gandr\u012bz 30 gadus ilga, un vi\u0146\u0161 specializ\u0113jies glob\u0101lu komerci\u0101lu strat\u0113\u0123iju izstr\u0101d\u0113, \u012bpa\u0161u uzman\u012bbu piev\u0113r\u0161ot cenu veido\u0161anai un piek\u013cuvei tirgum, pier\u0101d\u012bjumu b\u0101zes att\u012bst\u012bbai, vesel\u012bbas apr\u016bpes politikai, z\u0101\u013cu lai\u0161anas strat\u0113\u0123ij\u0101m tirg\u016b un uz v\u0113rt\u012bbu balst\u012btiem risin\u0101jumiem.\r\n\u0100dams pievienoj\u0101s IQVIA 2004. gad\u0101, un no 2010. l\u012bdz 2015. gadam vad\u012bja Cenu noteik\u0161anas un tirgus pieejam\u012bbas izcil\u012bbas centru Amerikas re\u0123ion\u0101. V\u0113l\u0101k vi\u0146\u0161 vad\u012bja Inov\u0101ciju un satura centru un bija vado\u0161ais klientspeci\u0101lists ASV Vid\u0113jo Rietumu un Atlantijas piekrastes re\u0123ionos.\r\nStr\u0101d\u0101jot IQVIA, \u0100dams ir konsult\u0113jis gan lielus, gan mazus biofarm\u0101cijas uz\u0146\u0113mumus, pal\u012bdzot tirg\u016b ieviest gan ni\u0161as z\u0101les, gan noz\u012bm\u012bgus prepar\u0101tus ar pla\u0161u pielietojumu. Vi\u0146a pieredze z\u012bmolu un portfe\u013cu strat\u0113\u0123ij\u0101 aptver piecus kontinentus un daudzas terapeitisk\u0101s jomas \u2013 s\u0101kot no prim\u0101r\u0101s un specializ\u0113t\u0101s apr\u016bpes l\u012bdz onkolo\u0123ijai, vakc\u012bn\u0101m un ret\u0101m slim\u012bb\u0101m.\r\nPirms pievieno\u0161an\u0101s IQVIA, \u0100dams bija akciju anal\u012bti\u0137is CIBC World Markets, kur specializ\u0113j\u0101s lielo un specializ\u0113to farm\u0101cijas uz\u0146\u0113mumu sektor\u0101, k\u0101 ar\u012b str\u0101d\u0101ja par vesel\u012bbas apr\u016bpes vad\u012bbas konsultantu Ernst & Young Consulting (tagad Cap Gemini).\r\n\u0100dams ir ieguvis uz\u0146\u0113m\u0113jdarb\u012bbas vad\u012bbas ma\u0123istra gr\u0101du Kolumbijas Biznesa skol\u0101 un bakalaura gr\u0101du politiskaj\u0101 ekonomik\u0101 Prinstonas Universit\u0101t\u0113, ASV."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2021\/12\/JohnFRyanphoto_final.jpg","name":"Inesa Aufi","position":"Asoci\u0113t\u0101 konsultante, Eiropas iniciat\u012bva par diskrimin\u0101cijas izskau\u0161anu pret v\u0113zi p\u0101rdz\u012bvoju\u0161ajiem","description":"Inesa Aufi jau vair\u0101kus gadus akt\u012bvi iesaist\u0101s Eiropas iniciat\u012bv\u0101, kuras m\u0113r\u0137is ir izbeigt diskrimin\u0101ciju pret v\u0113zi p\u0101rdz\u012bvoju\u0161ajiem, kop\u0101 ar iniciat\u012bvas vad\u012bt\u0101ju Dr. Fran\u00e7oise Meunier veicinot politiskus risin\u0101jumus nevienl\u012bdz\u012bbas mazin\u0101\u0161anai v\u0113zi p\u0101rdz\u012bvoju\u0161o cilv\u0113ku vid\u016b.\r\nVi\u0146a ir veikusi p\u0113t\u012bjumus par cilv\u0113kiem, kas p\u0101rcietu\u0161i v\u0113zi, k\u0101 ar\u012b par t\u0101 d\u0113v\u0113taj\u0101m \u201cties\u012bb\u0101m tikt aizmirstam\u201d, t\u0101 sniedzot ieguld\u012bjumu pier\u0101d\u012bjumos balst\u012bt\u0101 intere\u0161u aizst\u0101v\u012bb\u0101 gan Eiropas Savien\u012bbas, gan citu valstu l\u012bmen\u012b. 2024. gad\u0101 Inesa koordin\u0113ja augsta l\u012bme\u0146a konferences organiz\u0113\u0161anu par diskrimin\u0101cijas izskau\u0161anu pret v\u0113zi p\u0101rdz\u012bvoju\u0161ajiem."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/03\/Nicolo-Matteo-Luca-Battisti.png","name":"Nicol\u00f2 Matteo Luca Battisti","position":"Eiropas V\u0113\u017ea organiz\u0101cijas nevienl\u012bdz\u012bbas t\u012bkla l\u012bdzpriek\u0161s\u0113d\u0113t\u0101js","description":"Dr. Nikol\u00f2 Mateo Luka Batisti ir onkologs-konsultants Karaliskaj\u0101 M\u0101rzd\u0113nas slimn\u012bc\u0101 London\u0101, kur vi\u0146\u0161 vada Gados vec\u0101ku pacientu onkolo\u0123ijas programmu Kr\u016bts v\u0113\u017ea noda\u013c\u0101.\r\nVi\u0146\u0161 ieguva medic\u012bnas gr\u0101du Mil\u0101nas Universit\u0101t\u0113 2009. gad\u0101 un 2015. gad\u0101 pabeidza onkolo\u0123ijas rezident\u016bru Mil\u0101nas Nacion\u0101laj\u0101 V\u0113\u017ea instit\u016bt\u0101. 2022. gad\u0101 vi\u0146\u0161 ieguva doktora gr\u0101du p\u0113tniec\u012bb\u0101 (MD[Res]) Londonas V\u0113\u017ea izp\u0113tes instit\u016bt\u0101, koncentr\u0113joties uz v\u0113\u017ea \u0101rst\u0113\u0161anu gados vec\u0101kiem pacientiem. Papildus vi\u0146\u0161 ir absolv\u0113jis ESMO l\u012bderu att\u012bst\u012bbas programmu (2022) un ieguvis vesel\u012bbas ekonomikas un politikas sertifik\u0101tu Londonas Ekonomikas skol\u0101 (LSE) 2023. gad\u0101.\r\nDr. Batisti ir biju\u0161ais Starptautisk\u0101s Geriatrisk\u0101s onkolo\u0123ijas biedr\u012bbas (SIOG) prezidents un pa\u0161reiz\u0113jais Eiropas V\u0113\u017ea organiz\u0101cijas kasieris. Vi\u0146\u0161 ie\u0146em vado\u0161us amatus ar\u012b vair\u0101k\u0101s cit\u0101s profesion\u0101l\u0101s organiz\u0101cij\u0101s, tostarp EUSOMA, EORTC un NABCOP.\r\nVi\u0146a zin\u0101tnisk\u0101 darb\u012bba ir velt\u012bta kr\u016bts v\u0113\u017ea un geriatrisk\u0101s onkolo\u0123ijas jomai, \u012bpa\u0161i piev\u0113r\u0161oties blakus saslim\u0161an\u0101m, dz\u012bves kvalit\u0101tei un vesel\u012bbas apr\u016bpes nevienl\u012bdz\u012bbas jaut\u0101jumiem onkolo\u0123ij\u0101.\r\nDr. Batisti ir sa\u0146\u0113mis vair\u0101kus apbalvojumus, tostarp Arti Hurria balvu (2019) un Dario Cova balvu (2021)."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/03\/Karla-Hernandez-Villafuerte.jpg","name":"Karla Hernandez-Villafuerte","position":"Vec\u0101k\u0101 vesel\u012bbas ekonomikas p\u0113tniece, WifOR instit\u016bts","description":"Dr. Karla Ernandesa- Villafuerte ir ekonomiste un ekonometri\u0137e, kuras specializ\u0101cija ir jaunu vesel\u012bbas apr\u016bpes risin\u0101jumu kompens\u0101cijas l\u0113mumu ietekm\u0113jo\u0161o faktoru anal\u012bze.\r\nPa\u0161laik vi\u0146a str\u0101d\u0101 V\u0101cij\u0101, WifOR instit\u016bt\u0101, k\u0101 vec\u0101k\u0101 p\u0113tniece. Vi\u0146as darbs ir v\u0113rsts uz metodolo\u0123ijas izstr\u0101di, lai nov\u0113rt\u0113tu jaunu \u0101rstniec\u012bbas meto\u017eu apstiprin\u0101\u0161anas makroekonomiskos ieguvumus.\r\nIepriek\u0161 vi\u0146a bija vec\u0101k\u0101 p\u0113tniece V\u0101cijas V\u0113\u017ea p\u0113tniec\u012bbas centr\u0101 (DKFZ), kur Vesel\u012bbas ekonomikas noda\u013c\u0101 p\u0113t\u012bja v\u0113\u017ea rad\u012bto soci\u0101lekonomisko slogu pacientiem un vi\u0146u \u0123imen\u0113m, jaunu z\u0101\u013cu izp\u0113tes un att\u012bst\u012bbas (R&D) izmaksu noteico\u0161os faktorus, k\u0101 ar\u012b izv\u0113rt\u0113ja uz risku balst\u012btu prostatas un kr\u016bts v\u0113\u017ea skr\u012bninga programmu izmaksu efektivit\u0101ti V\u0101cij\u0101.\r\nPirms darba DKFZ Karla str\u0101d\u0101ja London\u0101, Vesel\u012bbas ekonomikas biroj\u0101 (OHE), kur vi\u0146a analiz\u0113ja statistiskos un vesel\u012bbas ekonomikas izaicin\u0101jumus onkolo\u0123ij\u0101, \u012bpa\u0161i saist\u012bb\u0101 ar datu ekstrapol\u0101ciju no slim\u012bbas progresijas aizkav\u0113\u0161an\u0101s uz kop\u0113jo izdz\u012bvo\u0161anu. T\u0101pat vi\u0146a piedal\u012bj\u0101s p\u0113t\u012bjumos par kvalitat\u012bvajiem un kvantitat\u012bvajiem r\u0101d\u012bt\u0101jiem, kas atspogu\u013co politisko ap\u0146\u0113m\u012bbu un progresu ce\u013c\u0101 uz visaptvero\u0161u vesel\u012bbas apr\u016bpes nodro\u0161in\u0101\u0161anu att\u012bst\u012bbas valst\u012bs."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/03\/Aija_Gerina_F.jpg","name":"Aija Geri\u0146a","position":"Latvijas Onkologu \u0137\u012bmijterapeitu asoci\u0101cijas valdes priek\u0161s\u0113d\u0113t\u0101ja","description":"Dr. Aija Geri\u0146a ir viena no vado\u0161aj\u0101m onkolo\u0123ijas nozares speci\u0101list\u0113m Latvij\u0101 ar vair\u0101k nek\u0101 20 gadu kl\u012bnisko, akad\u0113misko un zin\u0101tnisko pieredzi. Dr. Geri\u0146a vada Paula Stradi\u0146a Kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas Onkolo\u0123ijas kl\u012bniku un ir sertific\u0113ta \u0101rste onkolo\u0123ij\u0101 un \u0137\u012bmijterapij\u0101, Latvijas Universit\u0101tes Medic\u012bnas un dz\u012bv\u012bbas zin\u0101t\u0146u fakult\u0101tes un Kl\u012bnisk\u0101s un profilaktisk\u0101s medic\u012bnas instit\u016bta docente. \r\n  Zin\u0101\u0161anas padzi\u013cin\u0101jusi starptautisk\u0101s kl\u012bnik\u0101s, tostarp Karolinskas instit\u016bt\u0101 Stokholm\u0101 un Vivantes Friedrichshain kl\u012bnik\u0101 Berl\u012bn\u0113. Dr. Geri\u0146a ir Latvijas Onkologu \u0137\u012bmijterapeitu asoci\u0101cijas valdes priek\u0161s\u0113d\u0113t\u0101ja, k\u0101 ar\u012b akt\u012bva dal\u012bbniece Eiropas Onkologu \u0137\u012bmijterapeitu biedr\u012bb\u0101 (ESMO) un Latvijas \u0100rstu biedr\u012bb\u0101. Dr. Geri\u0146a ir vair\u0101ku zin\u0101tnisku publik\u0101ciju autore, regul\u0101ri piedal\u0101s starptautisk\u0101s konferenc\u0113s un akt\u012bvi iesaist\u0101s onkolo\u0123ijas izgl\u012bt\u012bbas un \u0101rst\u0113\u0161anas kvalit\u0101tes att\u012bst\u012bb\u0101 Latvij\u0101."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/04\/Bogi-Eliasen_F.png","name":"Bogi Eliasens","position":"Fonda \"Movement Health Foundation\" izpilddirektors, Kopenh\u0101genas N\u0101kotnes p\u0113t\u012bjumu instit\u016bta goda biedrs vesel\u012bbas n\u0101kotnes jaut\u0101jumos","description":"Bogi Eliasens ir \u201cMovement Health Foundation\u201d izpilddirektors un vada da\u017e\u0101das vesel\u012bbas iniciat\u012bvas, jo \u012bpa\u0161i v\u0113\u017ea un kardiometabolisko slim\u012bbu jom\u0101, sevi\u0161\u0137u uzman\u012bbu piev\u0113r\u0161ot valst\u012bm ar vid\u0113jiem ien\u0101kumiem. Dzimis F\u0113ru sal\u0101s, vi\u0146\u0161 stud\u0113jis politikas zin\u0101tni un starptautisk\u0101s ties\u012bbas Orh\u016bsas Universit\u0101t\u0113 un ieguvis vad\u012bbas izgl\u012bt\u012bbu H\u0101rvarda Kenedija skol\u0101.\r\nBogi ir bijis iniciators  gan \u201cFarGen\u201d iedz\u012bvot\u0101ju genoma projektam \u2013 pasaul\u0113 pirmajam valsts iedz\u012bvot\u0101ju genoma sekvenc\u0113\u0161anas projektam F\u0113ru sal\u0101s, gan iniciat\u012bvai \u201cNordic Health 2030\u201d, t\u0101 veicinot profilaktiskas un personaliz\u0113tas apr\u016bpes att\u012bst\u012bbu. Par savu darbu digit\u0101l\u0101s vesel\u012bbas jom\u0101 Bogi 2019. gad\u0101 sa\u0146\u0113ma \u201cHIMSS Future 50\u201d starptautisko sasniegumu balvu.\r\nBogi Eliasens ir HIMSS Zieme\u013cvalstu t\u012bkla priek\u0161s\u0113d\u0113t\u0101ja vietnieks, viens no \u201cMovement Health Foundation\u201d dibin\u0101t\u0101jiem un viens no galvenajiem glob\u0101l\u0101 Bio\u0113tikas t\u012bkla dal\u012bbniekiem. Bogi ar\u012b konsult\u0113 decentraliz\u0113tu kl\u012bnisko p\u0113t\u012bjumu jaut\u0101jumos un ir PVO Strat\u0113\u0123isko partneru iniciat\u012bvas datu un digit\u0101l\u0101s vesel\u012bbas jom\u0101 l\u012bdzpriek\u0161s\u0113d\u0113t\u0101js."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/03\/Zofia-Das-Gupta.jpg","name":"Zofia Das-Gupta","position":"Vec\u0101k\u0101 vesel\u012bbas izn\u0101kumu p\u0113tniec\u012bbas direktore, Starptautiskais Vesel\u012bbas rezult\u0101tu m\u0113r\u012bjumu konsorcijs (ICHOM)","description":"Zofia Das-Gupta ir l\u012bdere v\u0113rt\u012bb\u0101s balst\u012btas vesel\u012bbas apr\u016bpes un uz pier\u0101d\u012bjumiem balst\u012btas l\u0113mumu pie\u0146em\u0161anas att\u012bst\u012bb\u0101.\r\nK\u0101 ICHOM vec\u0101k\u0101 p\u0113tniec\u012bbas direktore vi\u0146a sadarbojas ar starptautiskajiem partneriem, lai ieviestu standartiz\u0113tus vesel\u012bbas rezult\u0101tu m\u0113r\u012bjumus un veicin\u0101tu datu efekt\u012bvu izmanto\u0161anu vesel\u012bbas sist\u0113m\u0101s, t\u0101 uzlabojot gan apr\u016bpes kvalit\u0101ti, gan resursu efektivit\u0101ti.\r\nZofia Das-Gupta regul\u0101ri uzst\u0101jas starptautisk\u0101s konferenc\u0113s par t\u0101d\u0101m t\u0113m\u0101m k\u0101 vesel\u012bbas apr\u016bpes rezult\u0101ti, digit\u0101l\u0101 vesel\u012bba un r\u012bc\u012bbpolitikas inov\u0101cijas. \r\nVi\u0146a iest\u0101jas par to, lai vesel\u012bbas apr\u016bpes praks\u0113 tiktu integr\u0113ta p\u0113tniec\u012bba un strat\u0113\u0123isks redz\u0113jums, t\u0101 nodro\u0161inot vislab\u0101kos pacientu vesel\u012bbas rezult\u0101tus."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/03\/Jacek_Maciejewski_FINAL-1.jpg","name":"Jaceks Macijevskis (Jacek Maciejewski)","position":"Rak'n'Roll Foundation valdes loceklis, Polija","description":"Jacek Maciejewski ir Rak'n'Roll Foundation valdes loceklis, vi\u0146a atbild\u012bba \u2013 fonda un t\u0101 z\u012bmola vad\u012bbu. Jaceks Macijevskis Var\u0161avas Universit\u0101t\u0113 ir ieguvis ma\u0123istra gr\u0101du pedago\u0123ij\u0101, k\u0101 ar\u012b pabeidzis p\u0113cdiploma kursu socioterapij\u0101. K\u0101du laiku str\u0101d\u0101jis kl\u012bnik\u0101, kas sniedz psiholo\u0123isko apr\u016bpi, bet kop\u0161 1996. gada nodarbojas ar rekl\u0101mu k\u0101 soci\u0101l\u0101s komunik\u0101cijas speci\u0101lists. Vi\u0146\u0161 izgudroja Rak'n'Roll fonda nosaukumu [\u2018rak' po\u013cu valod\u0101 noz\u012bm\u0113 \u2018v\u0113zis\u2019] un izveidoja t\u0101 komunik\u0101cijas strat\u0113\u0123iju. Vi\u0146\u0161 ir bijis atbild\u012bgs par liel\u0101ko da\u013cu fonda soci\u0101lo kampa\u0146u, kuru rezult\u0101t\u0101 \u0161\u012b NVO iemantojusi atpaz\u012bstam\u012bbu."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/04\/Alinta_Hegmane.jpg","name":"Alinta Hegmane","position":"Latvijas V\u0113\u017ea centra direktore","description":"Asoc. prof. Alinta Hegmane ir sertific\u0113ta onkolo\u0123e \u0137\u012bmijterapeite un Latvijas Universit\u0101tes asoci\u0113t\u0101 profesore. 1998. gad\u0101 absolv\u0113jusi Latvijas Medic\u012bnas akad\u0113miju, p\u0113c kuras pabeigusi rezident\u016bru onkolo\u0123ij\u0101 Latvijas Universit\u0101t\u0113. 2008. gad\u0101 ieguvusi medic\u012bnas zin\u0101t\u0146u doktora gr\u0101du (Dr.med.). Akt\u012bvi iesaist\u0101s studentu un rezidentu apm\u0101c\u012bb\u0101 gan Latvijas Universit\u0101t\u0113, gan R\u012bgas Stradi\u0146a universit\u0101t\u0113.\r\nAlinta Hegmane ir vado\u0161\u0101 p\u0113tniece kl\u012bniskajos p\u0113t\u012bjumos par kr\u016bts v\u0113zi, nes\u012bk\u0161\u016bnu plau\u0161u v\u0113zi, kolorekt\u0101lo v\u0113zi un v\u0113zi ar nezin\u0101mu prim\u0101ro lokaliz\u0101ciju. Vi\u0146as zin\u0101tniskie darbi ir public\u0113ti starptautiski cit\u0113jamos izdevumos. Vi\u0146a ir Latvijas Onkologu asoci\u0101cijas valdes priek\u0161s\u0113d\u0113t\u0101ja, Latvijas Onkologu \u0137\u012bmijterapeitu asoci\u0101cijas biedre, Eiropas Onkologu biedr\u012bbas (ESMO) biedre un kop\u0161 2025.gada marta ar\u012b Latvijas V\u0113\u017ea centra direktore."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/04\/Radu-Ganescu_F.jpg","name":"Radu Ganescu","position":"Rum\u0101nijas Hronisko slim\u012bbu pacientu organiz\u0101ciju nacion\u0101l\u0101s koal\u012bcijas (COPAC) prezidents","description":"Radu Ganesku ir ilggad\u0113js pacientu ties\u012bbu un kvalitat\u012bvas vesel\u012bbas apr\u016bpes pieejam\u012bbas aizst\u0101vis. 2004. gad\u0101 vi\u0146s l\u012bdzdibin\u0101ja Rum\u0101nijas Talas\u0113mijas slimnieku asoci\u0101ciju, lai pan\u0101ktu, ka pacientiem k\u013c\u016btu pieejamas lab\u0101kas \u0101rst\u0113\u0161anas iesp\u0113jas un liel\u0101kas izv\u0113les iesp\u0113jas. Vi\u0146a vad\u012bb\u0101 asoci\u0101cija pievienoj\u0101s Starptautiskajai talas\u0113mijas feder\u0101cijai, Nacion\u0101lajai reto slim\u012bbu aliansei un Rum\u0101nijas hronisko slim\u012bbu pacientu organiz\u0101ciju koal\u012bcijai, kuru vi\u0146\u0161 vada kop\u0161 2013. gada. Radu ir vad\u012bjis valsts m\u0113roga kampa\u0146as, lai veicin\u0101tu inform\u0113t\u012bbu, stiprin\u0101tu pacientu poz\u012bcijas un papla\u0161in\u0101tu pacientu kust\u012bbu Rum\u0101nij\u0101.\r\nEiropas l\u012bmen\u012b vi\u0146\u0161 2013. gad\u0101 pievienoj\u0101s Eiropas Pacientu foruma valdei un 2016. gad\u0101 k\u013cuva par t\u0101s finan\u0161u p\u0101rzini, t\u0101 atbalstot organiz\u0101ciju ar savu finan\u0161u pieredzi. Vi\u0146\u0161 ir ar\u012b pilsonisk\u0101s sabiedr\u012bbas p\u0101rst\u0101vis vesel\u012bbas jom\u0101 Rum\u0101nijas Ekonomikas un soci\u0101lo lietu padom\u0113. Radu ir ap\u0146\u0113m\u012bbas pilns nodro\u0161in\u0101t vienl\u012bdz\u012bgu piek\u013cuvi \u0101rst\u0113\u0161anai un stiprin\u0101t vesel\u012bbas apr\u016bpes sist\u0113mas un pacientu lomu taj\u0101s."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/04\/Maija_Abolina1.jpg","name":"Maija \u0100boli\u0146a","position":"Latvijas Republikas Valsts kontroles padomes locekle","description":"K\u0101 augst\u0101k\u0101s rev\u012bzijas iest\u0101des padomes locekle Maija \u0100boli\u0146a ir atbild\u012bga par lietder\u012bbas, atbilst\u012bbas un finan\u0161u rev\u012bzij\u0101m vesel\u012bbas apr\u016bpes, labkl\u0101j\u012bbas un izgl\u012bt\u012bbas nozar\u0113. Vi\u0146as vad\u012bb\u0101 veiktas rev\u012bzijas b\u0113rnu ties\u012bbu un soci\u0101lo pakalpojumu jom\u0101, k\u0101 ar\u012b sist\u0113miska rev\u012bzija onkolo\u0123ijas jom\u0101, sniedzot ieteikumus gan attiec\u012bb\u0101 uz agr\u012bn\u0101s diagnostikas p\u0101rvald\u012bbas procesiem, gan attiec\u012bb\u0101 uz kvalitat\u012bvu kompens\u0113jamo z\u0101\u013cu sist\u0113mu un to cenu regul\u0113jumu. Rev\u012bziju laik\u0101 un ieteikumu ievie\u0161anas uzraudz\u012bbas stadij\u0101 Maija \u0100boli\u0146a att\u012bst\u012bjusi cie\u0161u sadarb\u012bbu ar nevald\u012bbas organiz\u0101cij\u0101m un nozaru ekspertiem, kuru l\u012bdzdarbo\u0161an\u0101s rev\u012bzij\u0101m pie\u0161\u0137ir profesion\u0101lo kvalit\u0101ti. Vi\u0146ai ir akad\u0113misk\u0101s zin\u0101\u0161anas jurisprudenc\u0113 un vair\u0101k nek\u0101 desmit gadu profesion\u0101l\u0101 pieredze Latvijas Bank\u0101 Eirosist\u0113mas monet\u0101r\u0101s politikas oper\u0101ciju un \u0101r\u0113jo rezervju p\u0101rvald\u012b\u0161anas jom\u0101. Pirms darba uzs\u0101k\u0161anas Valsts kontrol\u0113, Maija \u0100boli\u0146a bija tieslietu ministra \u0101r\u0161tata padomniece finan\u0161u ties\u012bbu un publisk\u0101s p\u0101rvaldes jaut\u0101jumos."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/04\/Neringa_Ciakiene_F.jpg","name":"Neringa \u010cakiene","position":"Lietuvas V\u0113\u017ea pacientu koal\u012bcijas (POLA) direktore","description":"Neringa \u010cakiene ir pacientu aizst\u0101ve \u2013 vi\u0146a vada Lietuvas V\u0113\u017ea pacientu koal\u012bciju (POLA), liel\u0101ko pacientu organiz\u0101ciju Lietuv\u0101. Vi\u0146as kompetences jomas ir pacientu intere\u0161u aizst\u0101v\u012bba, komunik\u0101cija, l\u012bdzek\u013cu piesaiste un projektu vad\u012bba. Neringa, b\u016bdama pacientu organiz\u0101cijas seja un balss, iest\u0101jas par pacientu vajadz\u012bb\u0101m un v\u0113lm\u0113m, kas bie\u017ei vien p\u0101rsniedz vienas sist\u0113mas robe\u017eas un prasa m\u0113r\u0137tiec\u012bgu un m\u0113r\u0137tiec\u012bgu da\u017e\u0101du iest\u0101\u017eu un soci\u0101lo partneru r\u012bc\u012bbu. Neringa uzskata, ka veiksm\u012bgu rezult\u0101tu sasnieg\u0161anai nepiecie\u0161amas cie\u0146pilnas attiec\u012bbas, savlaic\u012bga iesaist\u012b\u0161an\u0101s, dal\u012bta atbild\u012bba, kompetence, pa\u0161atdeve un sasniegto rezult\u0101tu nov\u0113rt\u0113\u0161ana."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/04\/Marcis_Leja_F.jpg","name":"M\u0101rcis Leja","position":"LU Kl\u012bnisk\u0101s un profilaktisk\u0101s medic\u012bnas instit\u016bta direktors","description":"Dr. M\u0101rcis Leja ir Latvijas Universit\u0101tes Medic\u012bnas un dz\u012bv\u012bbas zin\u0101t\u0146u fakult\u0101tes profesors un LU Kl\u012bnisk\u0101s un profilaktisk\u0101s medic\u012bnas instit\u016bta direktors, k\u0101 ar\u012b eksperts zin\u0101tnes jom\u0101 R\u012bgas Austrumu kl\u012bniskaj\u0101 universit\u0101tes slimn\u012bc\u0101 un gastroenterologs Gremo\u0161anas slim\u012bbu centr\u0101. Dr. Leja specializ\u0113jas onkolo\u0123iskaj\u0101 profilaks\u0113, ku\u0146\u0123a un zarnu trakta audz\u0113ju agr\u012bn\u0101 diagnostik\u0101, mikrobioma izp\u0113t\u0113 un inovat\u012bv\u0101s diagnostikas metod\u0113s.\r\nM. Leja ir vado\u0161ais p\u0113tnieks gremo\u0161anas sist\u0113mas audz\u0113ju profilakses p\u0113t\u012bjum\u0101 GISTAR, ko \u012bsteno sadarb\u012bb\u0101 ar Pasaules Vesel\u012bbas organiz\u0101cijas Starptautisko v\u0113\u017ea p\u0113tniec\u012bbas a\u0123ent\u016bru (IARC). Dr. Leja koordin\u0113 Eiropas Savien\u012bbas Vienot\u0101s r\u012bc\u012bbas projektu v\u0113\u017ea skr\u012bninga jom\u0101 EUCanScreen, k\u0101 ar\u012b projektu \u201cCe\u013c\u0101 uz ku\u0146\u0123a v\u0113\u017ea skr\u012bninga ievie\u0161anu ES (TOGAS)\u201d. \r\nM.Leja ir Eiropas Helikobakt\u0113rijas un mikrobioma p\u0113t\u012bjumu grupas loceklis, Amerikas Gastroenterolo\u0123ijas asoci\u0101cijas \u012bstenais loceklis, daudzu starptautisku vadl\u012bniju darba grupas loceklis, k\u0101 ar\u012b Latvijas Zin\u0101t\u0146u akad\u0113mijas \u012bstenais loceklis. M.Leja ir bijis Eiropas Komisijas V\u0113\u017ea misijas padomes loceklis (2019\u20132021), Dr. Leja ir vair\u0101k nek\u0101 200 zin\u0101tnisku publik\u0101ciju un se\u0161u gr\u0101matu noda\u013cu autors. Vi\u0146\u0161 uztur cie\u0161u sadarb\u012bbu ar p\u0113tniekiem ne vien Eirop\u0101, bet ar\u012b \u0100zij\u0101 un Amerik\u0101."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/04\/Haralds_Plaudis_F-1.jpg","name":"Haralds Plaudis","position":"R\u012bgas Austrumu kl\u012bnisk\u0101s universit\u0101tes valdes loceklis","description":"Haralds Plaudis kop\u0161 2021. gada ir R\u012bgas Austrumu kl\u012bnisk\u0101s universit\u0101tes valdes loceklis ar atbild\u012bbu ar \u0101rstniec\u012bbas un apr\u016bpes darbu. Vienlaikus vi\u0146\u0161 p\u0101rrauga ar\u012b \u0137irur\u0123ijas virziena att\u012bst\u012bbu un sak\u0101rto\u0161anu slimn\u012bc\u0101, k\u0101 ar\u012b ir R\u012bgas Stradi\u0146a universit\u0101tes profesors. Zin\u0101tnisk\u0101 interese un praktisk\u0101 specializ\u0101cija saist\u012bta ar minim\u0101li invaz\u012bvo \u0137irur\u0123iju, pankreato-bili\u0101r\u0101s un aug\u0161\u0113j\u0101 ku\u0146\u0123a-zarnu trakta patolo\u0123ijas \u0137irur\u0123iskas \u0101rst\u0113\u0161anas iesp\u0113j\u0101m. Prof. Plaudis pirmais Latvij\u0101 ieviesis un att\u012bst\u012bjis vakuum-asist\u0113tas v\u0113dera dobuma sl\u0113g\u0161anas metodolo\u0123iju, holedohoskopijas metodi \u017eultsvadu akme\u0146u minim\u0101li invaz\u012bv\u0101 \u0101rst\u0113\u0161an\u0101, fluorescences efekta izmanto\u0161anu abdomin\u0101l\u0101 \u0137irur\u0123ij\u0101 (image guided surgery). \r\nL\u012bdztekus \u0137irur\u0123iskai darb\u012bbai no 2018. l\u012bdz 2021. gadam prof. Plaudis ir bijis Latvijas \u0136irurgu asoci\u0101cijas (L\u0136A) prezidents, k\u0101 ar\u012b Sertifik\u0101cijas komisijas priek\u0161s\u0113d\u0113t\u0101js. \r\nProf. Plaudis ir 120 zin\u0101tnisko publik\u0101ciju, taj\u0101 skait\u0101 30 starptautisku publik\u0101ciju, autors un l\u012bdzautors, vad\u012bjis promocijas darbus, l\u012bdzdarbojies valsts p\u0113t\u012bjumu programmu realiz\u0101cij\u0101, k\u0101 ar\u012b piedal\u012bjies starptautiskos p\u0113t\u012bjumos par hroniska pankreat\u012bta \u0137irur\u0123isku \u0101rst\u0113\u0161anu un ir noz\u012bm\u012bgu starptautisku vadl\u012bniju l\u012bdzautors."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/04\/Valts-Abols.jpg","name":"Valts \u0100bols","position":"B\u0113rnu kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas valdes priek\u0161s\u0113d\u0113t\u0101js","description":"Valts \u0100bols ir B\u0113rnu kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas (BKUS) valdes priek\u0161s\u0113d\u0113t\u0101js, \u0161o amatu ie\u0146emot kop\u0161 2017. gada. \r\nVi\u0146a vad\u012bb\u0101 slimn\u012bca ir nostiprin\u0101jusi savu k\u0101 vado\u0161\u0101s pediatrisk\u0101s apr\u016bpes iest\u0101des lomu Latvij\u0101 un \u0101rpus t\u0101s robe\u017e\u0101m, koncentr\u0113joties uz inov\u0101cij\u0101m, uz pacientu orient\u0113tu apr\u016bpi un strat\u0113\u0123isku att\u012bst\u012bbu b\u0113rnu vesel\u012bbas ekosist\u0113m\u0101.\r\nPirms pievieno\u0161an\u0101s BKUS Valts \u0100bols vair\u0101k nek\u0101 divas desmitgades str\u0101d\u0101ja farm\u0101cijas nozar\u0113, tostarp ie\u0146\u0113ma noz\u012bm\u012bgu amatu GlaxoSmithKline (GSK) Europe. Vi\u0146a pieredze gan korporat\u012bvaj\u0101, gan kl\u012bniskaj\u0101 vid\u0113 \u013cauj slimn\u012bcas nep\u0101rtrauktaj\u0101 att\u012bst\u012bb\u0101 apvienot strat\u0113\u0123isko dom\u0101\u0161anu ar iej\u016bt\u012bgu apr\u016bpi.\r\nValts \u0100bols akt\u012bvi darbojas da\u017e\u0101d\u0101s vesel\u012bbas apr\u016bpes un sabiedrisk\u0101s organiz\u0101cij\u0101s. Vi\u0146\u0161 ir Latvijas Lielo slimn\u012bcu asoci\u0101cijas priek\u0161s\u0113d\u0113t\u0101js un Eiropas B\u0113rnu slimn\u012bcu organiz\u0101cijas (ECHO) valdes loceklis, kur iest\u0101jas par b\u0113rnu apr\u016bpes uzlabo\u0161anu vis\u0101 Eirop\u0101. Turkl\u0101t vi\u0146\u0161 ir Latvijas liel\u0101k\u0101s slimn\u012bcas \u2013 R\u012bgas Austrumu kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas \u2013 padomes  loceklis."},{"image":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2025\/05\/Dheepa-Rajan_F.jpg","name":"D\u012bpa Rad\u017eana","position":"Vec\u0101k\u0101 padomniece vesel\u012bbas sist\u0113mu jaut\u0101jumos, Pasaules Vesel\u012bbas organiz\u0101cijas Eiropas Vesel\u012bbas politikas centrs","description":"Pirms pievieno\u0161an\u0101s Eiropas Nov\u0113ro\u0161anas centram vesel\u012bbas sist\u0113mu un politikas jaut\u0101jumos 2022. gad\u0101 D\u012bpa vair\u0101k nek\u0101 15 gadus str\u0101d\u0101jusi Pasaules Vesel\u012bbas organiz\u0101cijas (PVO) galvenaj\u0101 m\u012btn\u0113, kur ie\u0146\u0113ma da\u017e\u0101dus amatus jaut\u0101jumos, kas saist\u012bti ar vesel\u012bbas sist\u0113mu p\u0101rvald\u012bbu. Vi\u0146as darba lauks aptv\u0113ra nacion\u0101lo vesel\u012bbas pl\u0101no\u0161anu, vesel\u012bbas sist\u0113mu snieguma nov\u0113rt\u0113\u0161anu, l\u012bdzdal\u012bbas p\u0101rvald\u012bbu un prim\u0101ro vesel\u012bbas apr\u016bpi.\r\nD\u012bpa ir p\u0101rraudz\u012bjusi vair\u0101ku noz\u012bm\u012bgu publik\u0101ciju izdo\u0161anu, tostarp PVO rokasgr\u0101matu sabiedr\u012bbas l\u012bdzdal\u012bbai vesel\u012bbas politik\u0101, tematiskajam ce\u013cvedim prim\u0101r\u0101s vesel\u012bbas apr\u016bpes jom\u0101 un metodolo\u0123isko ietvaru vesel\u012bbas sist\u0113mas snieguma nov\u0113rt\u0113\u0161anai politikas anal\u012bzes kontekst\u0101.\r\nD\u012bpa ieguvusi \u0101rsta izgl\u012bt\u012bbu G\u0113tingenes Universit\u0101t\u0113 V\u0101cij\u0101, k\u0101 ar\u012b ma\u0123istra gr\u0101du vesel\u012bbas ekonomik\u0101 un politik\u0101 Apvienotaj\u0101 Karalist\u0113. Vi\u0146a aizst\u0101v\u0113jusi doktorant\u016bras disert\u0101ciju par tradicion\u0101lo medic\u012bnu Indij\u0101."}]},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Run\u0101t\u0101ji - Cancer Equality<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cancerequality.eu\/lv\/speakers-2025\/\" \/>\n<meta property=\"og:locale\" content=\"lv_LV\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Run\u0101t\u0101ji - Cancer Equality\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cancerequality.eu\/lv\/speakers-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Equality\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-26T08:07:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/onko_fb.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/speakers-2025\\\/\",\"url\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/speakers-2025\\\/\",\"name\":\"Run\u0101t\u0101ji - Cancer Equality\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/#website\"},\"datePublished\":\"2025-03-17T18:18:39+00:00\",\"dateModified\":\"2025-05-26T08:07:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/speakers-2025\\\/#breadcrumb\"},\"inLanguage\":\"lv-LV\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[[\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/speakers-2025\\\/\"]]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/speakers-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Speakers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/#website\",\"url\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/\",\"name\":\"Cancer Equality\",\"description\":\"On Equality in Beating Cancer\",\"publisher\":{\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"lv-LV\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/#organization\",\"name\":\"Cancer Equality\",\"url\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lv-LV\",\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cancerequality.eu\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/onko_fb.jpg\",\"contentUrl\":\"https:\\\/\\\/cancerequality.eu\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/onko_fb.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Cancer Equality\"},\"image\":{\"@id\":\"https:\\\/\\\/cancerequality.eu\\\/lv\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Run\u0101t\u0101ji - Cancer Equality","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cancerequality.eu\/lv\/speakers-2025\/","og_locale":"lv_LV","og_type":"article","og_title":"Run\u0101t\u0101ji - Cancer Equality","og_url":"https:\/\/cancerequality.eu\/lv\/speakers-2025\/","og_site_name":"Cancer Equality","article_modified_time":"2025-05-26T08:07:15+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/onko_fb.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cancerequality.eu\/lv\/speakers-2025\/","url":"https:\/\/cancerequality.eu\/lv\/speakers-2025\/","name":"Run\u0101t\u0101ji - Cancer Equality","isPartOf":{"@id":"https:\/\/cancerequality.eu\/lv\/#website"},"datePublished":"2025-03-17T18:18:39+00:00","dateModified":"2025-05-26T08:07:15+00:00","breadcrumb":{"@id":"https:\/\/cancerequality.eu\/lv\/speakers-2025\/#breadcrumb"},"inLanguage":"lv-LV","potentialAction":[{"@type":"ReadAction","target":[["https:\/\/cancerequality.eu\/lv\/speakers-2025\/"]]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cancerequality.eu\/lv\/speakers-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cancerequality.eu\/lv\/"},{"@type":"ListItem","position":2,"name":"Speakers"}]},{"@type":"WebSite","@id":"https:\/\/cancerequality.eu\/lv\/#website","url":"https:\/\/cancerequality.eu\/lv\/","name":"Cancer Equality","description":"On Equality in Beating Cancer","publisher":{"@id":"https:\/\/cancerequality.eu\/lv\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cancerequality.eu\/lv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"lv-LV"},{"@type":"Organization","@id":"https:\/\/cancerequality.eu\/lv\/#organization","name":"Cancer Equality","url":"https:\/\/cancerequality.eu\/lv\/","logo":{"@type":"ImageObject","inLanguage":"lv-LV","@id":"https:\/\/cancerequality.eu\/lv\/#\/schema\/logo\/image\/","url":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/onko_fb.jpg","contentUrl":"https:\/\/cancerequality.eu\/wp-content\/uploads\/2022\/01\/onko_fb.jpg","width":1200,"height":630,"caption":"Cancer Equality"},"image":{"@id":"https:\/\/cancerequality.eu\/lv\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/pages\/674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/comments?post=674"}],"version-history":[{"count":16,"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/pages\/674\/revisions"}],"predecessor-version":[{"id":931,"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/pages\/674\/revisions\/931"}],"wp:attachment":[{"href":"https:\/\/cancerequality.eu\/lv\/wp-json\/wp\/v2\/media?parent=674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}